可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1] Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes[J]. Diabetes, 2003, 52(10):2546-2553.[2] Fagerberg B, Hulten LM, Hulthe J. Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthymen: the atherosclerosis and insulin resistance study[J]. Metabolism, 2003, 52(11):1460-1463.[3] Torsello A, Bresciani E, Rossoni G, et al. Ghrelin plays a minor role in the physiological control of cardiac function in the rat[J]. Endocrinology, 2003, 144(5):1787-1792.[4] 任永生,常林,唐朝枢,等. Ghrelin对大鼠离体心脏缺血再灌注损伤的保护作用[J]. 中国药理学通报, 2003, 19(11):1269-1273.[5] Shimizu Y, Nagaya N, Teranishi Y, et al. Ghrelin improves endothelial dysfunction through growth hormone-independent mechanisms in rats[J]. Biochem Biophys Res Commun, 2003, 310(3):830-835.[6] Bedendi I, Alloatti G, Marcantoni A, et al. Cardiac efects of ghrelin and its endogenous derivatives des-octanoyl ghrelin and des-Glnl4-ghrelin[J]. Eur J Pharmacol, 2003, 476(1-2):87-95.[7] Li WG, Gavrila D, Liu XB. Ghrelin inhibits proinflammatory responses and nuclear factor-κB activation in human endothelial cells [J]. Circulation, 2004, 109(18):2221-2226. [8] Skilton MR, Nakhla S, Sieveking DP, et al. Pathophysiological levels of the obesity related peptides resistin and ghrelin increase adhesion molecule expression on human vascular endothelial cells[J]. Clin Exp Pharmacol Physiol, 2005, 32(10):839-844.[9] Suematsu M, Katsuki A, Sumida Y, et al. Decreased circulating levels of active ghrelin are associated with increased oxidative stress in obese subjects[J]. Eur J Endocrinol, 2005, 153(3):403-407.